Biology subjects

McCaw, Z. R.

Publications and source records attributed to McCaw, Z. R..

14 recordsLinked to original sources

bioRxiv2025

Large Impact of Genetic Data Processing Steps on Stability and Reproducibility of Set-Based Analyses in Genome-Wide Association Studies

Genome-wide association studies (GWAS) are crucial to human genetics research, yet their stability and reproducibility are often questioned. This work describes, analyzes, and provides tools for overcoming reproducibility challenges in two highly popular components of GWAS: set-based (a) hypothesis testing and (b) effect size estimation. Specifically, we focus on how the set-based natures of (a) and (b) often fuel non-reproducible results due to differences in data processing pipelines that are rarely discussed. First, we describe the processing challenges in a statistical model misspecification framework. Second, we analytically calculate the differences in power and amounts of bias that can arise in (a) and (b), respectively, due to small data processing choices. Third, we provide tools for quantifying and avoiding the data processing obstacles in GWAS. We validate our analytical calculations through a simulation study, and we demonstrate the aforementioned challenges empirically through analysis of a whole-exome sequencing study of pancreatic cancer. Author SummaryThe lack of reproducibility and stability in genome-wide association studies (GWAS) have been widely reported. Here, we demonstrate how such reproducibility challenges arise in a common component of GWAS, set-based hypothesis testing and estimation studies. Specifically, we show how minor, seemingly harmless decisions in how scientists prepare their data can lead to major differences in the final conclusions. These data processing steps are rarely reported in detail, further obscuring their importance. Our work precisely measures the impact of data processing steps on power and bias of common modeling approaches. As a partial solution for future GWAS, we also provide an R software package to interact with our results, which can be used to assess the impact of choices at the design stage of GWAS studies. We further analyze a pancreatic cancer dataset using two modern pipelines and show how the pipelines produce very different results for ATM, a gene that has been previously linked with pancreatic cancer. Using the tools provided by this work can help significantly improve the reproducibility and stability of set-based results, enhancing the translational potential of GWAS investigations.

genetics↗

bioRxiv2024

Extending the Coding-variant Allelic Series Test to Summary Statistics

Genes for which a dose-response relationship exists between mutational severity and phenotypic impact make for logical therapeutic targets, as the effects of pharmacological modulation can be anticipated from the natural variation present in a population. We refer to genes where such a dose-response relationship exists as harboring allelic series, and have introduced the rare coding-variant allelic series test (COAST) for their identification. The original COAST required access to individual-level data. However, such data are often unavailable due to privacy concerns or logistical challenges. Meanwhile, single-variant summary statistics of the type produced by genome-wide association studies are plentiful. Here we introduce COAST-SS, an extension of COAST that accepts summary statistics as input, namely the per-variant effect sizes and standard errors, along with estimates of the minor allele frequency and local linkage disequilibrium (LD). As a running example, we consider identifying allelic series for circulating lipid traits, drawing on data from the UK Biobank, Million Veterans Program, and Trans-Omics of Precision Medicine Program. Through extensive analyses of real and simulated data, we demonstrate that COAST-SS provides p-values effectively equivalent to those from the original COAST. Interestingly, we find that when LD is low, as is expected among rare variants, COAST-SS is robust to misspecification of the LD matrix, providing valid inference even when the LD matrix is set to the identity matrix. We explore several strategies for annotating the pathogenicity of variants supplied to COAST-SS, finding that they often yield similar power for detecting candidate allelic series. Lastly, we employ COAST-SS to screen for lipid trait allelic series in a meta-analyzed cohort of up to 840K subjects. COAST-SS has been incorporated into the publicly available AllelicSeries R package.

genetics↗

bioRxiv2024

Functional dissection of complex and molecular trait variants at single nucleotide resolution

Identifying the causal variants and mechanisms that drive complex traits and diseases remains a core problem in human genetics. The majority of these variants have individually weak effects and lie in non-coding gene-regulatory elements where we lack a complete understanding of how single nucleotide alterations modulate transcriptional processes to affect human phenotypes. To address this, we measured the activity of 221,412 trait-associated variants that had been statistically fine-mapped using a Massively Parallel Reporter Assay (MPRA) in 5 diverse cell-types. We show that MPRA is able to discriminate between likely causal variants and controls, identifying 12,025 regulatory variants with high precision. Although the effects of these variants largely agree with orthogonal measures of function, only 69% can plausibly be explained by the disruption of a known transcription factor (TF) binding motif. We dissect the mechanisms of 136 variants using saturation mutagenesis and assign impacted TFs for 91% of variants without a clear canonical mechanism. Finally, we provide evidence that epistasis is prevalent for variants in close proximity and identify multiple functional variants on the same haplotype at a small, but important, subset of trait-associated loci. Overall, our study provides a systematic functional characterization of likely causal common variants underlying complex and molecular human traits, enabling new insights into the regulatory grammar underlying disease risk.

genetics↗

bioRxiv2023

High-throughput ML-guided design of diverse single-domain antibodies against SARS-CoV-2

Treating rapidly evolving pathogenic diseases such as COVID-19 requires a therapeutic approach that accommodates the emergence of viral variants over time. Our machine learning (ML)-guided sequence design platform combines high-throughput experiments with ML to generate highly diverse single-domain antibodies (VHHs) that bind and neutralize SARS-CoV-1 and SARS-CoV-2. Crucially, the model, trained using binding data against early SARS-CoV variants, accurately captures the relationship between VHH sequence and binding activity across a broad swathe of sequence space. We discover ML-designed VHHs that exhibit considerable cross-reactivity and successfully neutralize targets not seen during training, including the Delta and Omicron BA.1 variants of SARS-CoV-2. Our ML-designed VHHs include thousands of variants 4-15 mutations from the parent sequence with significantly improved activity, demonstrating that ML-guided sequence design can successfully navigate vast regions of sequence space to unlock and future-proof potential therapeutics against rapidly evolving pathogens.

bioinformatics↗

bioRxiv2023

EmbedGEM: A framework to evaluate the utility of embeddings for genetic discovery

Machine learning (ML)-derived embeddings are a compressed representation of high content data modalities. Embeddings can capture detailed information about disease states and have been qualitatively shown to be useful in genetic discovery. Despite their promise, embeddings have a major limitation: it is unclear if genetic variants associated with embeddings are relevant to the disease or trait of interest. In this work we describe EmbedGEM (Embedding Genetic Evaluation Methods), a framework to systematically evaluate the utility of embeddings in genetic discovery. EmbedGEM focuses on comparing embeddings along two axes: heritability and disease relevance. As measures of heritability, we consider the number of genome-wide significant associations and the mean{chi} 2 statistic at significant loci. For disease relevance, we compute polygenic risk scores for each embedding principal component, then evaluate their association with high-confidence disease or trait labels in a held-out evaluation patient set. While our development of EmbedGEM is motivated by embeddings, the approach is generally applicable to multivariate traits, and can readily be extended to accommodate additional metrics along the evaluation axes. We demonstrate EmbedGEMs utility by evaluating embeddings and multivariate traits in two separate datasets: i) a synthetic dataset simulated to demonstrate the ability of the framework to correctly rank traits based on their heritability and disease relevance, and ii) a real data from the UK Biobank including metabolic and liver-related traits. Importantly, we show that greater disease relevance does not automatically follow from greater heritability.

bioinformatics↗

bioRxiv2023

A statistical framework for powerful multi-trait rare variant analysis in large-scale whole-genome sequencing studies

Large-scale whole-genome sequencing (WGS) studies have improved our understanding of the contributions of coding and noncoding rare variants to complex human traits. Leveraging association effect sizes across multiple traits in WGS rare variant association analysis can improve statistical power over single-trait analysis, and also detect pleiotropic genes and regions. Existing multi-trait methods have limited ability to perform rare variant analysis of large-scale WGS data. We propose MultiSTAAR, a statistical framework and computationally-scalable analytical pipeline for functionally-informed multi-trait rare variant analysis in large-scale WGS studies. MultiSTAAR accounts for relatedness, population structure and correlation among phenotypes by jointly analyzing multiple traits, and further empowers rare variant association analysis by incorporating multiple functional annotations. We applied MultiSTAAR to jointly analyze three lipid traits (low-density lipoprotein cholesterol, high-density lipoprotein cholesterol and triglycerides) in 61,861 multi-ethnic samples from the Trans-Omics for Precision Medicine (TOPMed) Program. We discovered new associations with lipid traits missed by single-trait analysis, including rare variants within an enhancer of NIPSNAP3A and an intergenic region on chromosome 1.

genetics↗

bioRxiv2023

Pitfalls in performing genome-wide association studies on ratio traits

Genome-wide association studies (GWAS) are often performed on ratios composed of a numerator trait divided by a denominator trait. Examples include body mass index (BMI) and the waist-to-hip ratio, among many others. Explicitly or implicitly, the goal of forming the ratio is typically to adjust for an association between the numerator and denominator. While forming ratios may be clinically expedient, there are several important issues with performing GWAS on ratios. Forming a ratio does not "adjust" for the denominator in the sense of conditioning on it, and it is unclear whether associations with ratios are attributable to the numerator, the denominator, or both. Here we demonstrate that associations arising in ratio GWAS can be entirely denominator-driven, implying that at least some associations uncovered by ratio GWAS may be due solely to a putative adjustment variable. In a survey of 10 common ratio traits, we find that the ratio model disagrees with the adjusted model (performing GWAS on the numerator while conditioning on the denominator) at around 1/3 of loci. Using BMI as an example, we show that variants detected by only the ratio model are more strongly associated with the denominator (height), while variants detected by only the adjusted model are more strongly associated with the numerator (weight). Although the adjusted model provides effect sizes with a clearer interpretation, it is susceptible to collider bias. We propose and validate a simple method of correcting for the genetic component of collider bias via leave-one-chromosome-out polygenic scoring.

genetics↗

bioRxiv2023

ChoruMM: a versatile multi-components mixed model for bacterial-GWAS

Genome-wide Association Studies (GWAS) have been central to studying the genetics of complex human outcomes, and there is now tremendous interest in implementing GWAS-like approaches to study pathogenic bacteria. A variety of methods have been proposed to address the complex linkage structure of bacterial genomes, however, some questions remain about to optimize the genetic modelling of bacteria to decipher causal variations from correlated ones. Here we examined the genetic structure underlying whole-genome sequencing data from 3,824 Listeria monocytogenes strains, and demonstrate that the standard human genetics model, commonly assumed by existing bacterial GWAS methods, is inadequate for studying such highly structured organisms. We leverage these results to develop ChoruMM, a robust and powerful approach that consists of a multi-component linear mixed model, where components are inferred from a hierarchical clustering of the bacteria genetic relatedness matrix. Our ChoruMM approach also includes post-processing and visualization tools that address the pervasive long-range correlation observed in bacteria genome and allow to assess the type I error rate calibration.

genetics↗

bioRxiv2022

An allelic series rare variant association test for candidate gene discovery

Allelic series are of candidate therapeutic interest due to the existence of a dose-response relationship between the functionality of a gene and the degree or severity of a phenotype. We define an allelic series as a gene in which increasingly deleterious mutations lead to increasingly large phenotypic effects, and develop a gene-based rare variant association test specifically targeted for the identification of allelic series. Building on the well-known burden and sequence kernel association (SKAT) tests, we specify a variety of association models, covering different genetic architectures, and integrate these into a COding-variant Allelic Series Test (COAST). Through extensive simulations, we confirm that COAST maintains the type I error and improves power when the pattern of coding-variant effect sizes increases monotonically with mutational severity. We applied COAST to identify allelic series for 4 circulating lipid traits and 5 cell count traits among 145,735 subjects with available whole exome sequencing data from the UK Biobank. Compared with optimal SKAT (SKAT-O), COAST identified 29% more Bonferroni significant associations with circulating lipid traits, on average, and 82% more with cell count traits. All of the gene-trait associations identified by COAST have corroborating evidence either from rare-variant associations in the full cohort (Genebass, N = 400K), or from common variant associations in the GWAS catalog. In addition to detecting many gene-trait associations present in Genebass using only a fraction (36.9%) of the sample, COAST detects associations, such as ANGPTL4 with triglycerides, that are absent from Genebass but which have clear common variant support.

genetics↗

bioRxiv2022

Leveraging a machine learning derived surrogate phenotype to improve power for genome-wide association studies of partially missing phenotypes in population biobanks

Within population biobanks, genetic discovery for specialized phenotypes is often limited by incomplete ascertainment. Machine learning (ML) is increasingly used to impute missing phenotypes from surrogate information. However, imputing missing phenotypes can invalidate statistical inference when the imputation model is misspecified, and proxy analysis of the ML-phenotype can introduce spurious associations. To overcome these limitations, we introduce SynSurr, an approach that jointly analyzes a partially missing target phenotype with a "synthetic surrogate", its predicted value from an ML-model. SynSurr estimates the same genetic effect as standard genome-wide association studies (GWAS) of the target phenotype, but improves power provided the synthetic surrogate is correlated with the target. Unlike imputation or proxy analysis, SynSurr does not require that the synthetic surrogate is obtained from a correctly specified generative model. We perform extensive simulations and an ablation analysis to compare SynSurr with existing methods. We also apply SynSurr to empower GWAS of dual-energy x-ray absorptiometry traits within the UK Biobank, leveraging a synthetic surrogate composed of bioelectrical impedance and anthropometric traits.

genetics↗

bioRxiv2020

Cross-tissue eQTL mapping in the presence of missing data via surrogate outcome analysis

Sample sizes vary substantially across tissues in the Genotype-Tissue Expression (GTEx) project, where considerably fewer samples are available from certain inaccessible tissues, such as the substantia nigra (SSN), than from accessible tissues, such as blood. This severely limits power for identifying tissue-specific expression quantitative trait loci (eQTL) in undersampled tissues. Here we propose Surrogate Phenotype Regression Analysis (SO_SCPLOWPRAYC_SCPLOW) for leveraging information from a correlated surrogate outcome (e.g. expression in blood) to improve inference on a partially missing target outcome (e.g. expression in SSN). Rather than regarding the surrogate outcome as a proxy for the target outcome, SO_SCPLOWPRAYC_SCPLOW jointly models the target and surrogate outcomes within a bivariate regression framework. Unobserved values of either outcome are treated as missing data. We describe and implement an expectation conditional maximization algorithm for performing estimation in the presence of bilateral outcome missingness. SO_SCPLOWPRAYC_SCPLOW estimates the same association parameter estimated by standard eQTL mapping and controls the type I error even when the target and surrogate outcomes are truly uncorrelated. We demonstrate analytically and empirically, using simulations and GTEx data, that in comparison with marginally modeling the target outcome, jointly modeling the target and surrogate outcomes increases estimation precision and improves power.

genetics↗

bioRxiv2020

Multitrait genetic-phenotype associations to connect disease variants and biological mechanisms

BackgroundGenome-wide association studies (GWAS) uncovered a wealth of associations between common variants and human phenotypes. These results, widely shared across the scientific community as summary statistics, fostered a flurry of secondary analysis: heritability and genetic correlation assessment, pleiotropy characterization and multitrait association test. Amongst these secondary analyses, a rising new field is the decomposition of multitrait genetic effects into distinct profiles of pleiotropy. ResultsWe conducted an integrative analysis of GWAS summary statistics from 36 phenotypes to decipher multitrait genetic architecture and its link to biological mechanisms. We started by benchmarking multitrait association tests on a large panel of phenotype sets and established the Omnibus test as the most powerful in practice. We detected 322 new associations that were not previously reported by univariate screening. Using independent significant associations, we investigated the breakdown of genetic association into clusters of variants harboring similar multitrait association profile. Focusing on two subsets of immunity and metabolism phenotypes, we then demonstrate how SNPs within clusters can be mapped to biological pathways and disease mechanisms, providing a putative insight for numerous SNPs with unknown biological function. Finally, for the metabolism set, we investigate the link between gene cluster assignment and success of drug targets in random control trials. We report additional uninvestigated drug targets classified by clusters. ConclusionsMultitrait genetic signals can be decomposed into distinct pleiotropy profiles that reveal consistent with pathways databases and random control trials. We propose this method for the mapping of unannotated SNPs to putative pathways.

genetics↗

bioRxiv2019

MGMM: an R package for fitting Gaussian Mixture Models on Incomplete Genomics Data

Although missing data are prevalent in applications, existing implementations of Gaussian mixture models (GMMs) require complete data. Standard practice is to perform complete case analysis or imputation prior to model fitting. Both approaches have serious drawbacks, potentially resulting in biased and unstable parameter estimates. Here we present MGMM, an R package for fitting GMMs in the presence of missing data. Using three case studies on real and simulated data sets, we demonstrate that, when the underlying distribution is near-to a GMM, MGMM is more effective at recovering the true cluster assignments than state of the art imputation followed by standard GMM. Moreover, MGMM provides an accurate assessment of cluster assignment uncertainty even when the generative distribution is not a GMM. This assessment may be used to identify unassignable observations. MGMM is available as an R package on CRAN: https://CRAN.R-project.org/package=MGMM.

bioinformatics↗

bioRxiv2019

Omnibus Inverse Normal Transformation Based Association Test Improves Power in Genome-Wide Association Studies of Quantitative Traits

SO_SCPLOWUMMARYC_SCPLOWQuantitative traits analyzed in Genome-Wide Association Studies (GWAS) are often non-normally distributed. For such traits, association tests based on standard linear regression are subject to reduced power and inflated type I error in finite samples. Applying the rank-based Inverse Normal Transformation (INT) to non-normally distributed traits has become common practice in GWAS. However, the different variations on INT-based association testing have not been formally defined, and guidance is lacking on when to use which approach. In this paper, we formally define and systematically compare the direct (D-INT) and indirect (I-INT) INT-based association tests. We discuss their assumptions, underlying generative models, and connections. We demonstrate that the relative powers of D-INT and I-INT depend on the underlying data generating process. Since neither approach is uniformly most powerful, we combine them into an adaptive omnibus test (O-INT). O-INT is robust to model misspecification, protects the type I error, and is well powered against a wide range of non-normally distributed traits. Extensive simulations were conducted to examine the finite sample operating characteristics of these tests. Our results demonstrate that, for non-normally distributed traits, INT-based tests outperform the standard untransformed association test (UAT), both in terms of power and type I error rate control. We apply the proposed methods to GWAS of spirometry traits in the UK Biobank. O-INT has been implemented in the R package RNOmni, which is available on CRAN.

genetics↗